Trial Profile
Case-control Study to Evaluate the Vaccine Effectiveness of Rotarix Against Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalised Children < 5 Years of Age in KK Hospital, Singapore.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs RIX 4414 (Primary)
- Indications Gastroenteritis; Rotavirus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 28 Nov 2011 Actual patient number changed from 1272 to 1270 according to ClinicalTrials.gov.
- 05 Aug 2010 Actual end date (1 Jul 2010) added as reported by ClinicalTrials.gov.
- 05 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.